Undertreatment improves, but overtreatment does not

JAMA Internal Medicine

Volumn 173, Issue 2, 2013, Pages 93-

  Katz, Mitchell H ^a   Grady, Deborah ^b   Redberg, Rita F ^b  

^a LOS ANGELES COUNTY DEPARTMENT OF HEALTH SERVICES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PROTON PUMP INHIBITOR;

AGE; CANCER SCREENING; EDITORIAL; FRACTURE; HUMAN; MORTALITY; OVERTREATMENT; PRESCRIPTION; PRIORITY JOURNAL; PROSTATE CANCER; THERAPEUTIC ERROR; THERAPY; ULCER; UNDERTREATMENT;

AMBULATORY CARE FACILITIES; FEMALE; HEALTH SERVICES MISUSE; HUMANS; MALE;

EID: 84873473630     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.2361     Document Type: Editorial

References (6)

1. Bennett CL. A 56-year-old physician who underwent a PSA test. Arch Intern Med. 2012;172(4):311.
2. Casner PR. A different perspective regarding prostate-specific antigen testing. Arch Intern Med. 2012;172(14):1110-1111.
3. Gomes T, Mamdani MM, Dhalla IA, Paterson JM, Juurlink DN. Opioid dose and drug-related mortality in patients with nonmalignant pain. Arch Intern Med. 2011;171(7):686-691.
4. Gray SL, La Croix AZ, Larson J, et al. Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative. Arch Intern Med. 2010;170(9):765-771.
5. Howell MD, Novack V, Grgurich P, et al. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med. 2010;170(9):784-790.
6. Kale MS, Bishop TF, Federman AD, Keyhani S. Trends in the overuse of ambulatory health care services in the United States [published online December 24, 2012]. JAMA Intern Med. 2013;173(2):142-148.